This site is operated by a business or businesses owned by
Informa PLC and all copyright resides with them. Informa PLC's
registered office is 5 Howick Place, London SW1P 1WG.
Registered in England and Wales. Number 8860726.
Your account has not been verified yet. Please click the
verification link in the email that has been sent to you.
If you need a new verification email, please click
here
and a new
one will be sent to the email address you provide.
Bifidobacterium Breve was first isolated from the feces of healthy breastfed infants by pediatrician Henry Tissier at the Pasteur Institute in France in 1899. It is native beneficial bacterium in the human gut.
Main characteristics of Bifidobacterium breve:*Strong acid resistance *Regulating gut microbiota *Great acid production ability *Improve sleep quality *Strong adhesion performance *Effectively enhance immunity *Intestinal colonization ability *Improve bioavailability *Promote allergic populations